The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Ipsen; Novartis; Pfizer
Pazopanib exposure-response assessment as adjuvant therapy for patients with localized or locally advanced renal cell carcinoma (RCC) following nephrectomy.
 
Cora N. Sternberg
No Relationships to Disclose
 
Frede Donskov
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
 
Naomi B. Haas
Consulting or Advisory Role - Exelixis; Novartis; Pfizer
 
Christian Doehn
Stock and Other Ownership Interests - AstraZeneca; Bayer; Bristol-Myers Squibb; Fresenius
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Novartis; Pfizer
 
Paul Russo
No Relationships to Disclose
 
Mohamed Elmeliegy
Employment - Novartis
Honoraria - Novartis
 
Hiya Banerjee
Employment - Merck
 
Paola Aimone
Employment - Novartis
Research Funding - Novartis
Travel, Accommodations, Expenses - Novartis
 
Maurizio Voi
Employment - Novartis
Stock and Other Ownership Interests - Bristol-Myers Squibb; Novartis; Pfizer
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb